English | Español
Patient Daily | Jan 17, 2026

Invisible hearing aids offer discreet solution for mild to moderate hearing loss
Patient Daily | Jan 17, 2026

Cancer treatments linked with increased risk of permanent or temporary hearing loss
Patient Daily | Jan 17, 2026

Hearing experts urge regular screening for those with autoimmune diseases
Patient Daily | Jan 16, 2026

Former Reps. Coelho, McMorris Rodgers on QALYs in federal programs: U.S. 'should not embrace health care rationing’
Patient Daily | Jan 16, 2026

Vedanta reduces workforce amid focus on phase III C. diff drug trial
Patient Daily | Jan 16, 2026

PhRMA senior manager on PBMs: 'Drug spending is nearly 200% higher per patient at 340B hospitals'
Patient Daily | Jan 16, 2026

Protagonist considers opting out of co-development after positive rusfertide trial results
Patient Daily | Jan 16, 2026

Novo Nordisk Foundation commits $850 million for European life sciences innovation

Trending
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor